US 12275786
Anti-thyroglobulin t cell receptors
granted A61KA61K2039/5156A61K38/00
Quick answer
US patent 12275786 (Anti-thyroglobulin t cell receptors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/5156, A61K38/00, A61K39/001144, A61P